Report cover image

Next generation Sequencing Market

Publisher Fortune Business Insights Pvt. Ltd.
Published Sep 01, 2024
Length 202 Pages
SKU # FOB19185524

Description

Next generation Sequencing Market



Growth Factors of Next-generation Sequencing Market

The next-generation sequencing market size was valued at USD 8.30 billion in 2023, and the market is now projected to grow from USD 9.29 billion in 2024 to USD 27.55 billion by 2032, exhibiting a CAGR of 14.6% during the forecast period of 2023-2030.

The COVID-19 pandemic created significant opportunities on the next-generation sequencing market growth as curbing coronavirus outbreak was prioritized. This technology changed into an effective tool for the analysis, tracking, and genomic studies of the SARS-CoV-2 virus. The pandemic elevated studies and investments in the improvement of vaccines in opposition to the virus.

The next-generation sequencing share globally has been contributed due to the diversified applications of next-generation sequencing. One of the distinguished elements that have contributed to the boom of the marketplace is various and increasing packages of next-technology sequencing in diagnostics. The declining expenses of sequencing have resulted in increasing packages of this technique inside the prognosis of numerous sicknesses.

Furthermore, there’s been a notable trend of increasing number of government-aided genome projects. Sequencing technologies, which include next-generation sequencing, play an important position in disorder analysis. With the emergence of NGS within the past decade, the panorama of disorder analysis and control has pretty modified. Owing to this, governments the world over have started investing an extensive amount in genomic tasks.

Comprehensive Analysis of Next-generation Sequencing Market

The next-generation sequencing market and medical device industry is rising at an exponential rate due to its market segmentation. This market expansion effectively provides a detailed regional assessment considering the dominant supply and demand forces that impact the medical device industry. These segmentations are methodically segregated by types of type, technology, application, and end user. The types include, Products {Instruments & Consumables}, and Services; By technology Sequencing By Synthesis (SBS), Nanopore Sequencing, ION Semiconductor Sequencing, and Others; By Application, Research & Applied and Clinical {Cardiovascular, Oncology, Genetic Diseases, Reproductive Health, and Others}; And by End-User, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Others.

The North American region is conducive to the global next-generation sequencing market, leading to a recall of USD 4.60 billion owing to growing research community. This can be attributed to factors, which include strong cognizance of the research network on genomics, excessive R&D investments, and a strong presence of nicely-installed organizations within the location. In addition, the growing introduction of new merchandise and collaborations and partnerships among players will support the local market’s boom.

The top players in the market play a crucial role in the medical device industry assuring industrial prospectus growth and setting market standards. These players include, Illumina Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), QIAGEN (Germany), PacBio (U.S.), Oxford Nanopore Technologies (U.K.), Perkin Elmer, Inc. (U.S.), and BGI (China) these market players provide a level-playing competitive landscape.

In February 2024, Integrated DNA Technologies (IDT) collaborated with Element Biosciences, Inc. to develop more streamlined NGS workflows.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2019-2032

Base Year 2023

Estimated Year 2024

Forecast Period 2024-2032

Historical Period 2019-2022

Growth Rate CAGR of 14.6% from 2024-2032

Unit Value (USD Billion)

Segmentation By Type

- Products
  • Instruments
  • Consumables
- Services

By Technology

- Sequencing By Synthesis (SBS)

- Nanopore Sequencing

- ION Semiconductor Sequencing

- Others

By Application

- Research & Applied

- Clinical
  • Cardiovascular
  • Oncology
  • Genetic Diseases
  • Reproductive Health
By End-User

- Pharmaceutical & Biotechnology Companies

- Academic & Research Institutes

- Others

By Region

- North America (By Type, Technology, Application, End-User, and Country)
  • U.S.
  • Canada
- Europe (By Type, Technology, Application, End-User, and Country/ Sub-Region)
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Scandinavia
  • Rest of Europe
- Asia Pacific (By Type, Technology, Application, End-User, and Country/ Sub-Region)
  • China
  • Japan
  • India
  • Australia
  • Southeast Asia
  • Rest of the Asia Pacific
- Latin America (By Type, Technology, Application, End-User, and Country/ Sub-Region)
  • Brazil
  • Mexico
  • Rest of Latin America
- Middle East & Africa (By Type, Technology, Application, End-User, and Country/ Sub-Region)
  • GCC
  • South Africa
  • Rest of the Middle East & Africa


    • Please Note: It will take 5-6 business days to complete the report upon order confirmation.

Table of Contents

202 Pages
1. Introduction
1.1. Market Scope
1.2. Market Segmentation
1.3. Market Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Market Trends
4. Key Insights
4.1. Prevalence of Key Diseases, By Key Countries, 2023
4.2. Overview: Regulatory Scenario & Reimbursement Scenario, By Key Countries/Region
4.3. New Product Launches, By Key Players
4.4. Key Industry Developments, By Key Players
4.5. Overview: Technological Advancements in Next-generation Sequencing
4.6. Impact of COVID-19 on the Market
5. Global Next-generation Sequencing Market Analysis, Insights and Forecast, 2019-2032
5.1. Market Analysis, Insights and Forecast - By Type
5.1.1. Products
5.1.1.1. Instruments
5.1.1.2. Consumables
5.1.2. Services
5.2. Market Analysis, Insights and Forecast - By Technology
5.2.1. Sequencing By Synthesis (SBS)
5.2.2. Nanopore Sequencing
5.2.3. ION Semiconductor Sequencing
5.2.4. Others
5.3. Market Analysis, Insights and Forecast - By Application
5.3.1. Research & Applied
5.3.2. Clinical
5.3.2.1. Cardiovascular
5.3.2.2. Oncology
5.3.2.3. Genetic Diseases
5.3.2.4. Reproductive Health
5.4. Market Analysis, Insights and Forecast - By End User
5.4.1. Pharmaceutical & Biotechnology Companies
5.4.2. Academic & Research Institutes
5.4.3. Others
5.5. Market Analysis, Insights and Forecast - By Region
5.5.1. North America
5.5.2. Europe
5.5.3. Asia Pacific
5.5.4. Latin America
5.5.5. Middle East & Africa
6. North America Next-generation Sequencing Market Analysis, Insights and Forecast, 2019-2032
6.1. Market Analysis, Insights and Forecast - By Type
6.1.1. Products
6.1.1.1. Instruments
6.1.1.2. Consumables
6.1.2. Services
6.2. Market Analysis, Insights and Forecast - By Technology
6.2.1. Sequencing By Synthesis (SBS)
6.2.2. Nanopore Sequencing
6.2.3. ION Semiconductor Sequencing
6.2.4. Others
6.3. Market Analysis, Insights and Forecast - By Application
6.3.1. Research & Applied
6.3.2. Clinical
6.3.2.1. Cardiovascular
6.3.2.2. Oncology
6.3.2.3. Genetic Diseases
6.3.2.4. Reproductive Health
6.4. Market Analysis, Insights and Forecast - By End User
6.4.1. Pharmaceutical & Biotechnology Companies
6.4.2. Academic & Research Institutes
6.4.3. Others
6.5. Market Analysis, Insights and Forecast - By Country
6.5.1. U.S.
6.5.2. Canada
7. Europe Next-generation Sequencing Market Analysis, Insights and Forecast, 2019-2032
7.1. Market Analysis, Insights and Forecast - By Type
7.1.1. Products
7.1.1.1. Instruments
7.1.1.2. Consumables
7.1.2. Services
7.2. Market Analysis, Insights and Forecast - By Technology
7.2.1. Sequencing By Synthesis (SBS)
7.2.2. Nanopore Sequencing
7.2.3. ION Semiconductor Sequencing
7.2.4. Others
7.3. Market Analysis, Insights and Forecast - By Application
7.3.1. Research & Applied
7.3.2. Clinical
7.3.2.1. Cardiovascular
7.3.2.2. Oncology
7.3.2.3. Genetic Diseases
7.3.2.4. Reproductive Health
7.4. Market Analysis, Insights and Forecast - By End User
7.4.1. Pharmaceutical & Biotechnology Companies
7.4.2. Academic & Research Institutes
7.4.3. Others
7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
7.5.1. U.K
7.5.2. Germany
7.5.3. France
7.5.4. Spain
7.5.5. Italy
7.5.6. Scandinavia
7.5.7. Rest of Europe
8. Asia Pacific Next-generation Sequencing Market Analysis, Insights and Forecast, 2019-2032
8.1. Market Analysis, Insights and Forecast - By Type
8.1.1. Products
8.1.1.1. Instruments
8.1.1.2. Consumables
8.1.2. Services
8.2. Market Analysis, Insights and Forecast - By Technology
8.2.1. Sequencing By Synthesis (SBS)
8.2.2. Nanopore Sequencing
8.2.3. ION Semiconductor Sequencing
8.2.4. Others
8.3. Market Analysis, Insights and Forecast - By Application
8.3.1. Research & Applied
8.3.2. Clinical
8.3.2.1. Cardiovascular
8.3.2.2. Oncology
8.3.2.3. Genetic Diseases
8.3.2.4. Reproductive Health
8.4. Market Analysis, Insights and Forecast - By End User
8.4.1. Pharmaceutical & Biotechnology Companies
8.4.2. Academic & Research Institutes
8.4.3. Others
8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
8.5.1. Japan
8.5.2. China
8.5.3. India
8.5.4. Australia
8.5.5. Southeast Asia
8.5.6. Rest of Asia Pacific
9. Latin America Next-generation Sequencing Market Analysis, Insights and Forecast, 2019-2032
9.1. Market Analysis, Insights and Forecast - By Type
9.1.1. Products
9.1.1.1. Instruments
9.1.1.2. Consumables
9.1.2. Services
9.2. Market Analysis, Insights and Forecast - By Technology
9.2.1. Sequencing By Synthesis (SBS)
9.2.2. Nanopore Sequencing
9.2.3. ION Semiconductor Sequencing
9.2.4. Others
9.3. Market Analysis, Insights and Forecast - By Application
9.3.1. Research & Applied
9.3.2. Clinical
9.3.2.1. Cardiovascular
9.3.2.2. Oncology
9.3.2.3. Genetic Diseases
9.3.2.4. Reproductive Health
9.4. Market Analysis, Insights and Forecast - By End User
9.4.1. Pharmaceutical & Biotechnology Companies
9.4.2. Academic & Research Institutes
9.4.3. Others
9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
9.5.1. Brazil
9.5.2. Mexico
9.5.3. Rest of Latin America
10. Middle East & Africa Next-generation Sequencing Market Analysis, Insights and Forecast, 2019-2032
10.1. Market Analysis, Insights and Forecast - By Type
10.1.1. Products
10.1.1.1. Instruments
10.1.1.2. Consumables
10.1.2. Services
10.2. Market Analysis, Insights and Forecast - By Technology
10.2.1. Sequencing By Synthesis (SBS)
10.2.2. Nanopore Sequencing
10.2.3. ION Semiconductor Sequencing
10.2.4. Others
10.3. Market Analysis, Insights and Forecast - By Application
10.3.1. Research & Applied
10.3.2. Clinical
10.3.2.1. Cardiovascular
10.3.2.2. Oncology
10.3.2.3. Genetic Diseases
10.3.2.4. Reproductive Health
10.4. Market Analysis, Insights and Forecast - By End User
10.4.1. Pharmaceutical & Biotechnology Companies
10.4.2. Academic & Research Institutes
10.4.3. Others
10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
10.5.1. GCC
10.5.2. South Africa
10.5.3. Rest of Middle East & Africa
11. Competitive Analysis
11.1. Global Market Share Analysis (2023)
11.2. Company Profiles
11.2.1. Illumina Inc.
11.2.1.1. Overview
11.2.1.2. Products & services
11.2.1.3. SWOT Analysis
11.2.1.4. Recent Developments
11.2.1.5. Strategies
11.2.1.6. Financials (Based on Availability)
11.2.2. Thermo Fisher Scientific Inc.
11.2.2.1. Overview
11.2.2.2. Products & services
11.2.2.3. SWOT Analysis
11.2.2.4. Recent Developments
11.2.2.5. Strategies
11.2.2.6. Financials (Based on Availability)
11.2.3. F. Hoffmann-La Roche Ltd.
11.2.3.1. Overview
11.2.3.2. Products & services
11.2.3.3. SWOT Analysis
11.2.3.4. Recent Developments
11.2.3.5. Strategies
11.2.3.6. Financials (Based on Availability)
11.2.4. QIAGEN
11.2.4.1. Overview
11.2.4.2. Products & services
11.2.4.3. SWOT Analysis
11.2.4.4. Recent Developments
11.2.4.5. Strategies
11.2.4.6. Financials (Based on Availability)
11.2.5. PacBio
11.2.5.1. Overview
11.2.5.2. Products & services
11.2.5.3. SWOT Analysis
11.2.5.4. Recent Developments
11.2.5.5. Strategies
11.2.5.6. Financials (Based on Availability)
11.2.6. Oxford Nanopore Technologies
11.2.6.1. Overview
11.2.6.2. Products & services
11.2.6.3. SWOT Analysis
11.2.6.4. Recent Developments
11.2.6.5. Strategies
11.2.6.6. Financials (Based on Availability)
11.2.7. Perkin Elmer, Inc.
11.2.7.1. Overview
11.2.7.2. Products & services
11.2.7.3. SWOT Analysis
11.2.7.4. Recent Developments
11.2.7.5. Strategies
11.2.7.6. Financials (Based on Availability)
11.2.8. BGI
11.2.8.1. Overview
11.2.8.2. Products & services
11.2.8.3. SWOT Analysis
11.2.8.4. Recent Developments
11.2.8.5. Strategies
11.2.8.6. Financials (Based on Availability)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us